Development of a novel osmotically driven drug delivery system for weakly basic drugs

Timmins, 1997, Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet, Pharm. Dev. Technol., 2, 25, 10.3109/10837459709022606 Varma, 2005, Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices, J. Control. Release, 103, 499, 10.1016/j.jconrel.2004.12.015 Vijay, 1988, Effect of the pH on the in vitro dissolution and in vivo absorption of controlled release theophylline in dogs, J. Pharm. Sci., 77, 760, 10.1002/jps.2600770908 Streubel, 2000, pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets, J. Control. Release, 67, 101, 10.1016/S0168-3659(00)00200-5 Gohel, 2003, Studies in preparation and evaluation of pH-independent sustained-release matrix tablets of verapamil HCl using directly compressible Eudragits, Pharm. Dev. Technol., 8, 323, 10.1081/PDT-120024686 Kranz, 2005, Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug, Eur. J. Pharm. Sci., 26, 47, 10.1016/j.ejps.2005.04.018 Kranz, 2005, Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug, Int. J. Pharm., 299, 84, 10.1016/j.ijpharm.2005.04.026 Siepe, 2006, Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH, Int. J. Pharm., 316, 14, 10.1016/j.ijpharm.2006.02.021 Siepe, 2006, Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study, J. Control. Release, 112, 72, 10.1016/j.jconrel.2005.12.021 Takka, 2001, Effect of anionic polymers on the drug release of propranolol hydrochloride from matrix tablets, Eur. J. Pharm. Biopharm., 52, 75, 10.1016/S0939-6411(01)00147-3 Lecomte, 2003, Blends of enteric and GIT-insoluble polymers used for film coating: physicochemical characterization and drug release patterns, J. Control. Release, 89, 457, 10.1016/S0168-3659(03)00155-X Amighi, 1998, Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. I. In vitro development and evaluation, Drug Dev. Ind. Pharm., 24, 509, 10.3109/03639049809085651 Dashevsky, 2004, pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat® SR 30 D and the enteric polymer dispersion Kollicoat® MAE 30 DP, Eur. J. Pharm. Biopharm., 58, 45, 10.1016/j.ejpb.2004.03.013 McGinity, 1997